Abstract:Introduction Balancing immunity and immunopathology at the sites of inflammation requires coordination of effector and regulatory immune mechanisms. Local immune responses to the infection, mechanical insult or an allograft result in the release of inflammatory mediators such as TLR ligands or proinflammatory cytokines. The ability of regulatory T cells (Treg) cells to respond to and suppress in the presence of inflammatory mediators is still not fully understood. From the perspective of clinical translation of Treg cell therapy for the organ transplantation, the investigation of the ability of Treg cells to mediate suppression in inflammatory conditions is extremely important. In this study, we investigated the impact of physiological amounts of IL-1&bgr; on Treg-mediated suppression and role of a decoy IL-1 receptor (IL-1RII) in Tregs ability to regulate the immune response. Material and Methods Sorted CD127loCD25+CD4+ human Tregs and CD127+CD25-CD4+ T effector cells (Teffs) have been expanded in vitro in the presence of anti-CD3/CD28 beads and recombinant IL-2 and the expression of IL-1 receptors have been evaluated using qPCR. Using co-culture experiments we tested the effects of IL-1&bgr; on the alloresponse and Tregs suppression. Next, utilising lentiviral IL-1RII silencing, neutralising antibodies and a combination of proliferation assays, intracellular signalling and cytokine production measurements we assessed the role of IL-1RII in human Tregs. Results Here, we demonstrated that physiological amounts of exogenousIL-1&bgr; significantly enhanced the proliferation and cytokine production by human T cells upon allostimulation. Interestingly, at high dose Tregs could neutralise the effect of IL-1&bgr; on both proliferation and cytokine secretion. When assessed for expression of IL-1 receptors, Treg cells responded to activation with increased expression of a decoy IL-1 receptor, IL-1RII, and by releasing soluble IL-1RII into the local microenvironment, whereas the expression of signal transducing receptor, IL-1RI, was similar in Treg and T effector cells. Next, using lentiviral silencing, we demonstrated that IL-1RII expression by human Tregs is necessary for efficient suppression of effector T cells proliferation and cytokine production, especially when tested in the presence of exogenous IL-1&bgr;. Conclusion We propose that the ability of Tregs to produce IL-1RII provides a decoy strategy to ensure regulation by modulating production of proinflammatory cytokines. As Treg cells present at the site of inflammation have important role in modulating the immune response, our data provide an important additional mechanism by which Treg cells ensure effective regulation in a proinflammatory microenvironment. European Society for Organ Transplantation, Junior Basic Science Research Grant.Kidney Research UK, SF1/2014.

Stat5 Polarization Promotes Itregs and Suppresses Human T-Cell Alloresponses While Preserving Ctl Capacity

Efficacy of Ctla4-Ig in Preventing Acute Rejection of Fully Allogeneic Heart Allografts in Sensitized Recipients

Impact of Regulatory T Cells on Innate Immune Cells in a Pre-Sensitized Heart Transplant Model

The Role of STAT3 in Antigen-Igg Inducing Regulatory CD4+Foxp3+T Cells

PRMT5 regulates epigenetic changes in suppressive Th1-like iTregs in response to IL-12 treatment

Antigen-Dependent Suppression of Alloresponses by Foxp3-Induced Regulatory T Cells in Transplantation

Dissociating STAT4 and STAT5 Signaling Inhibitory Functions of SOCS3: Effects on CD8 T Cell Responses

Short-term Pharmacological Inhibition of MyD88 Homodimerization by a Novel Inhibitor Promotes Robust Allograft Tolerance in Mouse Cardiac and Skin Transplantation.

Conferring alloantigen specificity to regulatory T cells: A comparative analysis of cell preparations undergoing clinical development in transplantation

STAT3 protects hematopoietic stem cells by preventing activation of a deleterious autocrine type-I interferon response

Tissue-infiltrating Alloreactive T Cells Require Id3 to Deflect PD-1-mediated Immune Suppression during GVHD

A Novel Mechanism of Human Regulatory T cell Function in Proinflammatory Conditions

Ex Vivo Expansion of Human Tregs Specific for Alloantigens Presented Directly or Indirectly.

Induced regulatory T cells modified by knocking down T-bet in combination with ectopic expression of inhibitory cytokines effectively protect graft-versus-host disease.

Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance.

Reduced Satb1 expression predisposes CD4+ T conventional cells to Treg suppression and promotes transplant survival

Stabilization of Foxp3 by Targeting JAK2 Enhances Efficacy of CD8 Induced Regulatory T Cells in the Prevention of Graft-versus-Host Disease.

Inhibiting STAT5 by the BET Bromodomain Inhibitor JQ1 Disrupts Human Dendritic Cell Maturation

Polyclonally Derived Alloantigen-Specific T Regulatory Cells Exhibit Target-Specific Suppression and Capture MHC Class II from Dendritic Cells

METTL3 inhibition reduces N6 -methyladenosine levels and prevents allogeneic CD4+ T-cell responses

Human OX40L-CAR-Tregs target activated antigen-presenting cells and control T cell alloreactivity